Adaptimmune Therapeutics (NASDAQ:ADAP) Cut to Sell at BidaskClub

Retrieved on: 2018-11-26 14:45:00

Tags for this article:

Click the tags to see associated articles and topics

Adaptimmune Therapeutics (NASDAQ:ADAP) Cut to Sell at BidaskClub. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc bought a new position in shares of Adaptimmune Therapeutics in the third quarter valued at approximately $1,220,000. Finally ...</div>

Article found on:

View Original Article